Latest Breaking News On - Institutional investors weigh in on infinity pharmaceuticals - Page 1 : comparemela.com

StockNews com Begins Coverage on Infinity Pharmaceuticals (NASDAQ:INFI)

StockNews.com initiated coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Free Report) in a research report report published on Sunday morning. The firm issued a hold rating on the biotechnology company’s stock. Infinity Pharmaceuticals Stock Up 12.0 % Shares of NASDAQ INFI opened at $0.10 on Friday. The firm has a 50-day simple moving average […]

Infinity pharmaceuticals incInfinity pharmaceuticalsCharles schwab investment management incNews ratings for infinity pharmaceuticals dailyInstitutional investors weigh in on infinity pharmaceuticalsGoldman sachs group incMillennium managementInfinity pharmaceuticals stockFree reportGet free reportStreet corpSchwab investment managementSachs groupJane street groupInfinity pharmaceuticals dailyNasdaq infi

Infinity Pharmaceuticals (NASDAQ:INFI) Coverage Initiated by Analysts at StockNews com

Infinity Pharmaceuticals (NASDAQ:INFI) Coverage Initiated by Analysts at StockNews com
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Renaissance technologiesNews ratings for infinity pharmaceuticals dailyInfinity pharmaceuticals stock performanceCharles schwab investment management incMirabella financial servicesInstitutional investors weigh in on infinity pharmaceuticalsInfinity pharmaceuticalsMillennium managementInfinity pharmaceuticals incFree reportSchwab investment managementStreet corpFinancial servicesGet free reportInfinity pharmaceuticals daily

Infinity Pharmaceuticals (NASDAQ:INFI) Now Covered by StockNews com

Infinity Pharmaceuticals (NASDAQ:INFI) Now Covered by StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Infinity pharmaceuticalsInfinity pharmaceuticals company profileInfinity pharmaceuticals incInstitutional investors weigh in on infinity pharmaceuticalsNews ratings for infinity pharmaceuticals dailyMirabella financial servicesVirtu financialInfinity pharmaceuticals stock downCallan capitalGet free reportPharmaceuticals stock downFinancial servicesSigma investmentsStreet groupInfinity pharmaceuticals daily

Infinity Pharmaceuticals (NASDAQ:INFI) Coverage Initiated by Analysts at StockNews com

Infinity Pharmaceuticals (NASDAQ:INFI) Coverage Initiated by Analysts at StockNews com
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Infinity pharmaceuticals incVirtu financialInfinity pharmaceuticals stock performanceInstitutional investors weigh in on infinity pharmaceuticalsMirabella financial servicesInfinity pharmaceuticalsInfinity pharmaceuticals company profileWittenberg investment management incNews ratings for infinity pharmaceuticals dailyFree reportGet free reportSigma investmentsInvestment managementFinancial servicesJane street groupInfinity pharmaceuticals daily

StockNews com Begins Coverage on Infinity Pharmaceuticals (NASDAQ:INFI)

StockNews.com began coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI – Get Rating) in a research note issued to investors on Friday morning. The brokerage issued a hold rating on the biotechnology company’s stock. Separately, Piper Sandler reaffirmed a neutral rating on shares of Infinity Pharmaceuticals in a research report on Friday, February 24th. Infinity Pharmaceuticals […]

Piper sandlerInfinity pharmaceuticalsMillennium managementWittenberg investment management incInfinity pharmaceuticals incInfinity pharmaceuticals trading downRenaissance technologiesNews ratings for infinity pharmaceuticals dailyInstitutional investors weigh in on infinity pharmaceuticalsCallan capitalGet ratingPharmaceuticals trading downInvestment managementInfinity pharmaceuticals dailyNasdaq infiInitiated coverage